Telaprevir impairs renal function and increases blood ribavirin concentration during telaprevir/pegylated interferon/ribavirin therapy for chronic hepatitis C

We aimed to examine the relationship between renal dysfunction and anaemia that may develop during combination therapy involving pegylated interferon, ribavirin and telaprevir (PEG-IFN/RBV/TVR) for the treatment of chronic hepatitis C. Sixty-eight patients with genotype 1b high viral loads were trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Karino, Y, Ozeki, I, Hige, S, Kimura, M, Arakawa, T, Nakajima, T, Kuwata, Y, Sato, T, Ohmura, T, Toyota, J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4282353/
https://www.ncbi.nlm.nih.gov/pubmed/24001168
http://dx.doi.org/10.1111/jvh.12162

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4282353/
https://www.ncbi.nlm.nih.gov/pubmed/24001168
http://dx.doi.org/10.1111/jvh.12162

Ejemplares similares